Eric S Groves - Net Worth and Insider Trading
Eric S Groves Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric S Groves owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Eric S Groves’s form 4 insider trades.
Insider Ownership Summary of Eric S Groves
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LGND | Ligand Pharmaceuticals Inc | 2006-03-10 | V-P & Project Management |
Eric S Groves Trading Performance
Eric S Groves Ownership Network
Eric S Groves Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Eric S Groves is the V-P & Project Management of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Eric S Groves made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 54,701 shares made by Matthew E Korenberg , a net sale of 11,800 shares made by Andrew Reardon , and a net sale of 13,433 shares made by Octavio Espinoza .
In summary, during the past 3 months, insiders sold 38,603 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 2,500 shares, with a net sale of 36,103 shares. During the past 18 months, 100,021 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 93,521 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Eric S Groves Mailing Address
Above is the net worth, insider trading, and ownership report for Eric S Groves. You might contact Eric S Groves via mailing address: C/o Ligand Pharmaceuticals Inc.,, 10275 Science Center Dr., San Diego Ca 92121.